Abstract:1333 Objectives Anti-angiogenic therapy (AAT) has become the major anticancer treatment strategies and there is an urgent need to monitor AAT response by noninvasive, functional molecular imaging with PET/CT since the tumor shrinkage maybe absent for AAT. This study aimed to monitor Sunitinib-based AAT response in mouse U87MG tumor models using 18F-FLT and 18F-FDG MicroPET/CT, comparatively. Methods U87MG tumor models in female nude mice were established and separated into two groups. Both groups were treated by the intragastrical injection of Sunitinib at a dose of 80 mg/kg for 7 days. The MicroPET/CT imaging of both 18F-FDG and 18F-FLT were acquired using MicroPET/CT scanner (Inveon) at day 0, 1, 3, 7 and 13 after AAT. The regions of interest within tumor tissues were delineated and the maximum Stanardized Uptake Values (SUVmax) were applied for the quantitative analysis. The tumor tissues were collected to perform Ki-67, Glut-1 and CD31 staining for immunohistochemical analysis. Data were expressed as mean ± SD and analyzed using One-Way ANOVA test and Pearson correlation analysis. Results Both 18F-FLT and 18F-FDG MicroPET/CT imaging were applied into monitoring AAT response in mouse U87MG tumor models. SUVmax of 18F-FLT uptake post AAT decreased significantly at day 1 (1.57 ± 0.06, P = 0.009), 3 (1.70 ± 0.10, P = 0.034), 7 (1.33 ± 0.15, P = 0.001), then raised at day 13 (1.87 ± 0.38, P = 0.162), comparing with baseline uptake at day 0 (2.13 ± 0.23). Notably, there were no significant differences for 18F-FLT uptakes at days post AAT. However, for 18F-FDG uptakes, there were no significant changes between post and prior AAT, with the exception that an increased SUVmax was observed at day 3 (2.33 ± 0.47), comparing with that at day 0 (1.68 ± 0.43, P = 0.013). Moreover, AAT was confirmed by CD31 staining, and the probe uptakes were correlated with the positive radios of Ki-67 and Glut-1 in tumor tissues. Conclusions MicroPET/CT imaging with 18F-FLT could be superior to that with 18F-FDG for monitoring anti-angiogenic therapy response. Research Support This study was supported by National Natural Science Foundation of China (No. 11275050, No. 30700188).

Monitoring of Tumor Response to Au Nanorod-Indocyanine Green Conjugates Mediated Therapy with Fluorescence Imaging and Positron Emission Tomography

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Ultra-Small and Metabolizable Near-Infrared Au/Gd Nanoclusters for Targeted FL/MRI Imaging and Cancer Theranostics

Radiolabeled AIE Probes As Dual-modality Imaging Agents for PET/NIR-II Fluorescence-Guided Photothermal Therapy

Monitoring of tumor response to cisplatin with simultaneous fluorescence and positron emission tomography: a feasibility study.

Non-Invasively Evaluating Therapeutic Response of Nanorod-Mediated Photothermal Therapy on Tumor Angiogenesis

Monitoring Response To Gefitinib In Nude Mouse Tumor Xenografts By F-18-Fdg Micropet-Ct: Correlation Between F-18-Fdg Uptake And Pathological Response

Monitoring Anti-Angiogenic Therapy Response in Mouse U87MG Tumor Model Using 18F-FLT and 18F-FDG Micropet/ct

Monitoring Of Tumor Response To Cisplatin By Subsurface Fluorescence Molecular Tomography

X‐Ray Activatable Au/Ag Nanorods for Tumor Radioimmunotherapy Sensitization and Monitoring of the Therapeutic Response Using NIR‐II Photoacoustic Imaging

Multimodal Imaging-Guided Strategy for Developing 177Lu-Labeled Metal-Organic Framework Nanomedicine with Potential in Cancer Therapy

Longitudinal Monitoring Of Tumor Antiangiogenic Therapy With Near-Infrared Fluorophore-Labeled Agents Targeted To Integrin Alpha(V)Beta(3) And Vascular Endothelial Growth Factor

18F-Labeled Magnetic Nanoparticles for Monitoring Anti-Angiogenic Therapeutic Effects in Breast Cancer Xenografts.

Longitudinal monitoring of tumor antiangiogenic therapy with near-infrared fluorophore-labeled agents targeted to integrin α v β 3 and vascular endothelial growth factor

Feasibility of Monitoring Tumor Response by Tracking Nanoparticle-Labelled T Cells Using X-ray Fluorescence Imaging—A Numerical Study

PET/NIR Fluorescence Bimodal Imaging for Targeted Tumor Detection

Multifunctional Gold Nanostar Conjugates for Tumor Imaging and Combined Photothermal and Chemo-Therapy.

Monitoring Tumor Targeting and Treatment Effects of IRDye 800CW and GX1-Conjugated Polylactic Acid Nanoparticles Encapsulating Endostar on Glioma by Optical Molecular Imaging.

A Non-Intrusive Evaluation Method for Tumor-Targeting Characteristics of Nanomedicines Based on in Vivo Near-Infrared Fluorescence Imaging.

Indocyanine Green Loaded Magnetic Carbon Nanoparticles for Near Infrared Fluorescence/Magnetic Resonance Dual-Modal Imaging and Photothermal Therapy of Tumor

Determination of subsurface tumor localization in animal models with near-infrared (NIR) fluorescence imaging